Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.20.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Equity [Abstract]  
Stock Option Outstanding, Beginning Balance | shares 99,833
Stock Option Outstanding, Granted | shares
Stock Option Outstanding, Cancelled | shares
Stock Option Outstanding, Exercised | shares
Stock Option Outstanding, Ending Balance | shares 99,833
Stock Option Outstanding, Exercisable Ending Balance | shares 96,532
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 27.81
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Cancelled | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Ending Balance | $ / shares 27.81
Weighted Average Exercise Price, Exercisable Ending Balance | $ / shares $ 28.36
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 2 years 7 days
Weighted Average Remaining Contractual Term (years), Outstanding Ending 1 year 9 months 7 days
Weighted Average Remaining Contractual Term (years), Exercisable Ending 1 year 8 months 16 days
Aggregated Intrinsic Value, Outstanding Ending | $
Aggregated Intrinsic Value, Exercisable Ending | $